Skip to main content
Skip to main content
GLOH logo

Glow Holdings, Inc. (GLOH) Stock Analysis

Educational signal · not a buy or sell recommendation · How to read this

$3.75 $0.00 (0.00%) |CouncilSplit View · 47 · C
MCap: $379M| Vol: 1| 52-wk range: $0.255 – $4.50

Market cap $379M is the value of all shares combined.

Data from FMP · Methodology

For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 17, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Quick Answer

Glow Holdings, Inc. (GLOH) trades at $3.75. Glow Holdings Inc. operates GlohCo, an AI-powered healthcare software platform in the United States. Market cap: $379M, Sector: Financial services.

Price as of Sep 11, 2026 · Last analyzed: Mar 17, 2026
Glow Holdings Inc. operates GlohCo, an AI-powered healthcare software platform in the United States. The platform analyzes medical data to predict patient relapse and readmission, integrating with existing electronic health record systems.

Analyst Coverage for GLOH: GLOH does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates GLOH against Financial Services peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.

Watch the GLOH film Every key number, told as a short cinematic story — just press play. ~2 min

Dated analysis: the newest financial statements on file are 24 months old (Sep 1, 2024), so the figures and score below describe that period, not today.

No score published: this stock trades under $10,000 on a typical day, so the price beside it is not one you could reliably act on.

Council Score · Weighted Average of 3 Disciplines
Split View 47/100 · C

GLOH: 1/2 scored disciplines lean bearish. Dominant signal: Ray Dalio bullish.

How is this calculated? →
Legends Council · 5 Legends + Moon AI

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated)Ray Dalio
Favorable read
Englander-style lens (simulated)Izzy Englander
Favorable read
Klarman-style lens (simulated)Seth Klarman
Neutral read
Moon AI lens (model)
Neutral read
Munger's Mindset · Balance Sheet & Valuation
Financial Health
Weak
Margin of Safety
Overvalued
Council Score · Weighted Average of 3 Disciplines · See tabs for details →
The lenses are modelled on the published principles of the investors named. We are not affiliated with them, they have not endorsed this, and it is not their opinion of this stock.

Glow Holdings, Inc. (GLOH) Financial Services Profile

Employees2
HeadquartersHouston, United States

Glow Holdings Inc., operating in the Financial Services sector as a shell company, focuses on its AI-powered healthcare software, GlohCo. The platform analyzes medical data to predict patient relapse and readmission, offering integration with electronic health record systems and compliance support for healthcare institutions in the United States.

Data Provenance | Financial Data Quantitative Analysis Analysis: Mar 17, 2026

What Is the Investment Thesis for GLOH?

AI-written as of Mar 17, 2026 — figures and tone reflect the data available then, not today's score.

Glow Holdings Inc. presents a speculative investment opportunity due to its focus on AI-powered healthcare solutions. The company's GlohCo platform, designed to predict patient relapse and readmission, addresses a significant need in the healthcare industry. However, with a small market capitalization of $379M and a beta of -2.14, the stock exhibits high volatility and risk. The absence of a dividend further reduces its appeal to income-seeking investors. The success of Glow Holdings hinges on the adoption and effectiveness of its GlohCo platform, as well as its ability to navigate the complex regulatory landscape of the healthcare industry.

Based on FMP financials and quantitative analysis

GLOH Key Highlights

AI-written as of Mar 17, 2026 — figures and tone reflect the data available then, not today's score.

Market capitalization of $379M indicates a micro-cap company with high growth potential but also significant risk.

  • Beta of -2.14 suggests the stock price moves inversely to the market, potentially offering diversification benefits during market downturns, but also indicating idiosyncratic risks.
  • The company operates GlohCo, an AI-powered healthcare software platform, indicating a focus on innovative technology within the healthcare sector.
  • GlohCo integrates with existing electronic health record systems, facilitating adoption by healthcare providers.
  • The company's platform supports compliance for hospitals, telehealth providers, and research institutions, addressing a critical need in the healthcare industry.

Who Are GLOH's Competitors?

GLOH is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap MoonshotScore
WENN Wen Acquisition Corp $10.39 +0.04% $390M 535-pillar
RDAG Republic Digital Acquisition Company $10.45 +0.19% $392M 495-pillar
TACO Berto Acquisition Corp. $10.48 -0.10% $393M 525-pillar
ALUB ALUB $10.12 0.00% $364M 405-pillar
TACH Titan Acquisition Corp. $10.50 0.00% $362M 465-pillar
CCII Cohen Circle Acquisition Corp. II $10.32 +0.05% $358M 485-pillar
BEAG Bold Eagle Acquisition Corp. $10.77 -0.28% $337M 525-pillar
RTAC Renatus Tactical Acquisition Corp I $10.44 -0.14% $325M 465-pillar

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are GLOH's Key Strengths?

AI-powered platform with predictive analytics capabilities.

  • Integration with existing electronic health record systems.
  • Focus on reducing patient relapse and readmission rates.
  • Support for regulatory compliance in the healthcare industry.

What Are GLOH's Weaknesses?

Small market capitalization and limited financial resources.

  • Dependence on the success of a single product, GlohCo.
  • Limited brand recognition and market presence.
  • Pending AI analysis creates uncertainty about the platform's effectiveness.

What Could Drive GLOH Stock Higher?

GLOH catalyst: Completion and publication of AI analysis results, which could validate the effectiveness of the GlohCo platform.

  • Increasing adoption of AI-powered healthcare solutions by hospitals and telehealth providers.
  • Potential partnerships with major healthcare organizations to implement GlohCo.

What Are the Key Risks for GLOH?

Failure to achieve widespread adoption of the GlohCo platform.

  • Inability to compete with larger, more established healthcare IT vendors.
  • Changes in healthcare regulations that could impact the company's business model.
  • Negative beta indicating sensitivity to market downturns and idiosyncratic risks.
  • Limited financial resources may hinder growth and expansion efforts.

What Are the Growth Opportunities for GLOH?

  • Expansion into Telehealth: Glow Holdings can capitalize on the growing telehealth market by integrating GlohCo with telehealth platforms. The telehealth market is projected to reach $550 billion by 2027, driven by increasing access to healthcare and convenience for patients. By offering AI-powered risk predictions within telehealth settings, Glow Holdings can enhance remote patient monitoring and improve outcomes, differentiating itself from competitors.
  • Partnerships with Hospitals: Collaborating with hospitals to implement GlohCo within their existing infrastructure presents a significant growth opportunity. Hospitals are increasingly seeking AI solutions to improve efficiency, reduce readmissions, and enhance patient care. By demonstrating the value of GlohCo through pilot programs and case studies, Glow Holdings can secure long-term contracts and expand its market reach.
  • Development of Personalized Medicine Applications: Leveraging the data collected by GlohCo, Glow Holdings can develop personalized medicine applications that tailor treatment plans to individual patient needs. The personalized medicine market is expected to reach $2.4 trillion by 2030, driven by advancements in genomics and data analytics. By offering personalized risk predictions and treatment recommendations, Glow Holdings can improve patient outcomes and gain a competitive edge.
  • Geographic Expansion: Expanding its operations beyond the United States presents a significant growth opportunity for Glow Holdings. The global healthcare market is vast and diverse, with varying levels of AI adoption and regulatory requirements. By targeting specific regions with favorable market conditions and adapting GlohCo to local needs, Glow Holdings can diversify its revenue streams and accelerate its growth.
  • Integration with Wearable Devices: Integrating GlohCo with wearable devices, such as smartwatches and fitness trackers, can provide real-time patient data and enhance risk predictions. The wearable device market is experiencing rapid growth, driven by increasing consumer awareness of health and wellness. By leveraging wearable data, Glow Holdings can gain a more comprehensive understanding of patient health and provide more personalized interventions.

What Threats Does GLOH Face?

  • Intense competition from established healthcare IT vendors and AI startups.
  • Complex regulatory requirements and data privacy concerns.
  • Potential for technological obsolescence.
  • Negative beta indicating sensitivity to market downturns.

What Are GLOH's Competitive Advantages?

  • Proprietary AI algorithms for predicting patient relapse and readmission.
  • Integration with existing electronic health record systems, creating switching costs for customers.
  • Compliance support for hospitals, telehealth providers, and research institutions.
  • First-mover advantage in the AI-powered healthcare software market.

What Does GLOH Do?

Glow Holdings Inc., formerly known as GlobalOne Real Estate, Inc., underwent a transformation in August 2011 to focus on AI-driven healthcare solutions. Incorporated in 1997 and based in Houston, Texas, the company operates GlohCo, an AI-powered healthcare software platform designed to improve patient outcomes and reduce healthcare costs. GlohCo ingests and analyzes diverse data types, including medical records, behavioral data, and wearable sensor data, to generate risk predictions for patient relapse, hospital readmission, and other high-cost health events. The platform's capabilities extend to seamless integration with existing electronic health record (EHR) systems, ensuring compatibility with established healthcare workflows. Furthermore, GlohCo supports compliance with regulatory requirements for hospitals, telehealth providers, and research institutions, addressing a critical need in the healthcare industry. Glow Holdings aims to provide healthcare providers with actionable insights derived from AI, enabling them to deliver more proactive and personalized care, ultimately improving patient outcomes and reducing the financial burden on the healthcare system.

What Products and Services Does GLOH Offer?

  • Operates GlohCo, an AI-powered healthcare software platform.
  • Ingests and analyzes medical, behavioral, and wearable data.
  • Delivers risk predictions for patient relapse and readmission.
  • Integrates with existing electronic health record systems.
  • Supports compliance for hospitals, telehealth providers, and research institutions.
  • Provides actionable insights to healthcare providers for proactive patient care.

How Does GLOH Make Money?

  • Generates revenue through licensing fees for the GlohCo platform.
  • Offers subscription-based access to GlohCo's AI-powered analytics.
  • Provides customized integration services for electronic health record systems.
  • Potentially generates revenue through data analytics and personalized medicine applications.

What Industry Does GLOH Operate In?

Glow Holdings Inc. operates within the rapidly evolving healthcare technology sector, where AI and machine learning are increasingly being adopted to improve patient care and reduce costs. The market for AI in healthcare is projected to experience substantial growth, driven by factors such as the increasing volume of healthcare data, the need for more efficient healthcare delivery, and the growing adoption of electronic health records. However, the industry is also characterized by intense competition, complex regulatory requirements, and the need for robust data security and privacy measures. Glow Holdings competes with established healthcare IT vendors and emerging AI startups, requiring continuous innovation and strategic partnerships to gain market share.

Who Are GLOH's Key Customers?

  • Hospitals seeking to reduce readmission rates and improve patient outcomes.
  • Telehealth providers looking to enhance remote patient monitoring and care.
  • Research institutions conducting clinical trials and healthcare studies.
  • Healthcare organizations seeking to comply with regulatory requirements.
Model self-rating on this text: 64% (not a measure of the evidence) Updated: Mar 17, 2026

Research confidence

Low 23/100

Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.

  • Scoring coverage unknown
  • Price is current
  • Latest filing 438 days ago
  • No analyst coverage

MoonshotScore History

Recorded daily since 2026-08-23 · 19 snapshots

2026-08-23 44
2026-08-26 44
2026-08-29 44
2026-09-01 44
2026-09-04 44
2026-09-07 44
2026-09-10 44

What changed?

The score has stayed at 44.

Over the same 18 days the stock moved +0.0%.

Company Profile

Glow Holdings, Inc. operates in the Financial - Conglomerates industry within the Financial Services sector. It is headquartered in Seattle, US. The company is led by CEO Alonzo V. Pierce. GLOH has traded publicly since 1998.

GLOH Revenue & Earnings Trend

In Q4 FY2024, GLOH generated $0 in top-line revenue. The company recorded a net loss of $31K, with diluted EPS of $-0.00. Quarter-over-quarter revenue has been mixed, typical for a small-cap company operating in Financial Services. Across the four most recent quarters, GLOH averaged $0.00 in diluted EPS.

Glow Holdings, Inc. (GLOH) Valuation Context

Valued at $379M, GLOH is classified as a small-cap stock.

Key Financial Metrics

Its free cash flow yield is -0.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.07 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is 0.0%, the inverse of the P/E and a quick read on earnings relative to price.

GLOH Financials

Fundamental Snapshot

Return on Equity (TTM)
-160.1%
Current Ratio
0.1

Based on FMP financials and quantitative analysis

Bull Case vs Bear Case

Bull Case

  • AI-powered platform with predictive analytics capabilities.
  • Integration with existing electronic health record systems.
  • Focus on reducing patient relapse and readmission rates.
  • Support for regulatory compliance in the healthcare industry.

Bear Case

  • Small market capitalization and limited financial resources.
  • Dependence on the success of a single product, GlohCo.
  • Limited brand recognition and market presence.
  • Pending AI analysis creates uncertainty about the platform's effectiveness.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026

Recent Quarterly Results

Quarter Revenue Net Income EPS
Q4 FY2024 $0 -$30,990 -$0.0001
Q2 FY2024 $0 $98,080 $0.0006
Q1 FY2024 $0 -$927 -$0.0000
Q4 FY2023 $0 -$8,636 -$0.0001

Q4 FY2024 · filed 30 Jun 2025 · SEC EDGAR →

Based on FMP financials and quantitative analysis

GLOH Latest News

No recent news available for GLOH.

GLOH Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for GLOH.

Price Targets

Wall Street price target analysis for GLOH.

GLOH MoonshotScore

MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for GLOH; grades run from A+ (80-100) to F (below 30).

GLOH OTC Market Information

GLOH trades on the OTC Other market tier of OTC Markets.

  • OTC Tier: OTC Other

GLOH Financial Services Stock FAQ

Is GLOH a good stock?

Stock Expert AI does not rate GLOH buy, sell or hold. Glow Holdings, Inc. has no MoonshotScore yet; read the financial checkup, analyst consensus and risks directly. Whether it fits is your call: check what it sells, whether it earns, what the price assumes, and what would prove you wrong.

What do analysts say about GLOH stock?

Currently, there is no available analyst coverage for Glow Holdings Inc. (GLOH). The company's small market capitalization and limited trading volume may contribute to the lack of analyst interest. Investors should conduct their own due diligence and carefully consider the risks and potential rewards before investing in GLOH.

What are the main risks for GLOH?

Glow Holdings Inc. faces several risks, including its small market capitalization, dependence on a single product (GlohCo), and intense competition in the healthcare IT sector.

What are the key factors to evaluate for GLOH?

Evaluate GLOH on fundamentals, analyst consensus, and risk factors. Glow Holdings Inc. presents a speculative investment opportunity due to its focus on AI-powered healthcare solutions. Not financial advice.

How frequently does GLOH data refresh on this page?

GLOH's price was last updated on Sep 11, 2026 and refreshes on page view during U.S. market hours; the quote is a provider snapshot, not an exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.

What has driven GLOH's recent stock price performance?

Glow Holdings, Inc. (GLOH) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: AI-powered platform with predictive analytics capabilities. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider GLOH overvalued or undervalued right now?

Glow Holdings, Inc. (GLOH) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

Can I buy fractional shares of GLOH?

Yes, most major brokerages offer fractional shares of Glow Holdings, Inc. (GLOH) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Information is based on limited data available.
Data Sources
Financial Modeling Prep (FMP)Stock Expert AI proprietary analysis

More Stocks We Cover